GENinCode Plc (LON:GENI – Get Free Report)’s share price traded down 10.3% during trading on Monday . The company traded as low as GBX 5.55 ($0.07) and last traded at GBX 5.55 ($0.07). 259,150 shares changed hands during mid-day trading, an increase of 3% from the average session volume of 251,898 shares. The stock had previously closed at GBX 6.19 ($0.08).
GENinCode Stock Down 2.0 %
The company has a market capitalization of £10.84 million, a P/E ratio of -104.17 and a beta of 0.62. The company has a current ratio of 5.92, a quick ratio of 15.89 and a debt-to-equity ratio of 6.74. The stock’s fifty day moving average is GBX 6.57 and its 200 day moving average is GBX 6.26.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Featured Articles
- Five stocks we like better than GENinCode
- What is a Death Cross in Stocks?
- Lumen’s Q2: Can AI Revenue Outshine a Mountain of Debt?
- What is the Euro STOXX 50 Index?
- Carry Trade Ending: Recent Market Turbulence and Future Risks
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Stocks Slide: Trillions Lost, More Downside Ahead?
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
